Literature DB >> 22526146

Clarifications on oxycodone-naloxone combination in cancer pain management.

Sebastiano Mercadante.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22526146     DOI： 10.1007/s00520-012-1449-0

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  6 in total

1.  The use of high doses of oxycodone in an acute palliative care unit.

Authors:  Sebastiano Mercadante; Patrizia Ferrera; Fabrizio David; Alessandra Casuccio
Journal:  Am J Hosp Palliat Care       Date:  2010-09-08       Impact factor: 2.500

2.  High doses of oxycodone-naloxone combination may provide poor analgesia.

Authors:  Sebastiano Mercadante; Patrizia Ferrera; Claudio Adile
Journal:  Support Care Cancer       Date:  2011-06-09       Impact factor: 3.603

Review 3.  Opioid titration in cancer pain: a critical review.

Authors:  Sebastiano Mercadante
Journal:  Eur J Pain       Date:  2007-02-28       Impact factor: 3.931

4.  A model of acute symptom control unit: Pain Relief and Palliative Care Unit of La Maddalena Cancer Center.

Authors:  Sebastiano Mercadante; Patrizia Villari; Patrizia Ferrera
Journal:  Support Care Cancer       Date:  2002-11-14       Impact factor: 3.603

5.  Clinical and financial analysis of an acute palliative care unit in an oncological department.

Authors:  S Mercadante; G Intravaia; P Villari; P Ferrera; F David; A Casuccio; S Mangione
Journal:  Palliat Med       Date:  2008-09       Impact factor: 4.762

6.  A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain.

Authors:  Sam H Ahmedzai; Friedemann Nauck; Gil Bar-Sela; Björn Bosse; Petra Leyendecker; Michael Hopp
Journal:  Palliat Med       Date:  2011-09-21       Impact factor: 4.762
  6 in total
  2 in total

Review 1.  New developments in the treatment of opioid-induced gastrointestinal symptoms.

Authors:  Jasper Pannemans; Tim Vanuytsel; Jan Tack
Journal:  United European Gastroenterol J       Date:  2018-08-27       Impact factor: 4.623

2.  Oxycodone/Naloxone: role in chronic pain management, opioid-induced constipation, and abuse deterrence.

Authors:  Anne Z DePriest; Katie Miller
Journal:  Pain Ther       Date:  2014-05-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.